These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5733328)

  • 1. [The use of Dopan in the treatment of pigmentary degeneration of the retina and atrophy of the optic nerve].
    Frantseva IA
    Oftalmol Zh; 1968; 23(2):145. PubMed ID: 5733328
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of dopan in thrombosis of the central vein of the retina].
    Kartasheva EA
    Vestn Oftalmol; 1967; 80(3):25-7. PubMed ID: 5615713
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of subleukemic myeloleukosis with Dopan].
    Morozova VT; Miroshnichenko IS; Terent'eva NI
    Ter Arkh; 1967 Feb; 39(2):19-20. PubMed ID: 5611685
    [No Abstract]   [Full Text] [Related]  

  • 4. [New method of treating patients with rheumatoid arthritis using electrophoresis of the immunosuppressive preparation dopan from a dimexide solution].
    Kozlova LA; Tereshina LG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1986; (1):33-5. PubMed ID: 3518232
    [No Abstract]   [Full Text] [Related]  

  • 5. [Irrigation system "Meturakol" in the treatment of dystrophic processes of the posterior eye segment].
    Sidorenko EI; Podyninogin NV
    Vestn Oftalmol; 2000; 116(4):30-1. PubMed ID: 11031874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrasonic therapy of patients with pigment degeneration of the retina and partial atrophy of the optic nerve].
    Marmur RK
    Oftalmol Zh; 1969; 24(3):192-6. PubMed ID: 5805835
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Result of use of dopan in treatment of chronic myeloleukosis].
    MOKEEVA RA
    Sov Med; 1958 Sep; 22(9):42-6. PubMed ID: 13615483
    [No Abstract]   [Full Text] [Related]  

  • 9. Leber's congenital tapetoretinal degeneration.
    Francois J
    Int Ophthalmol Clin; 1968; 8(4):929-47. PubMed ID: 5741529
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of dopan therapy of lymphogranulomatosis based on the data of the Khirgizin Scientific Research Institute of Oncology and Radiology].
    Sikorskaia IaV
    Sov Zdravookhr Kirg; 1965; 2():34-8. PubMed ID: 4221039
    [No Abstract]   [Full Text] [Related]  

  • 11. [Attempts at treating optic nerve atrophy with nitrogranulogen].
    Kubatko E
    Klin Oczna; 1971; 41(2):215-9. PubMed ID: 5575390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experimentation of a new drug based on retinal lipids and phospholipids of the optic pathways in certain degenerative diseases of the retina].
    Sborgia G; Lafronza V; Balestrazzi E
    Ann Ottalmol Clin Ocul; 1968 Sep; 94(9):1157-67. PubMed ID: 5734877
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructure of the preretinal membrane in retinitis pigmentosa.
    Szamier RB
    Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):227-36. PubMed ID: 7251306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrostimulation as a treatment method in partial atrophy of the optic nerve and retinal diseases].
    Rogatina EV
    Vestn Oftalmol; 1997; 113(1):41-3. PubMed ID: 9133046
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the biological activity of uracil mustard and Dopan.
    PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS
    Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713
    [No Abstract]   [Full Text] [Related]  

  • 16. [The protective effect of AET, cystamine and cystaphos when using lethal doses of antineoplastic drugs].
    Larionov LF; Spasskaia IG
    Vopr Onkol; 1968; 14(12):33-9. PubMed ID: 5714181
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the problem of the clinical picture and treatment of pigmental degeneration of the retina].
    Kulesh AP
    Oftalmol Zh; 1966; 21(5):346-9. PubMed ID: 6000796
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful treatment of lead atrophy of the optic nerve with unithiol].
    Dambite GR
    Oftalmol Zh; 1966; 21(5):329-31. PubMed ID: 6000794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nitrogranulogen in the treatment of cases of optic nerve diseases].
    Aleksandrowicz J; Kubatko E; Szmigiel Z
    Pol Tyg Lek; 1965 Oct; 20(40):1507-8. PubMed ID: 5849348
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of dopan poisoning].
    Kravets MG; Fleĭshman RP; Osinskiĭ VV; Rolenkova GA
    Vrach Delo; 1971 Dec; 12():112-3. PubMed ID: 5137844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.